These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36517057)

  • 1. The incidence and impact of anosmia on daily life after COVID-19 infection: A cross-sectional study in a tertiary center in Saudi Arabia.
    Bukhari AF; Malas M; Hanbazazah K; Zawawi F
    Saudi Med J; 2022 Dec; 43(12):1354-1362. PubMed ID: 36517057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of anosmia/hyposmia in post-COVID-19 patients: a cross-sectional study in an eastern province of Saudi Arabia.
    Mohamed R; Alsuhibani R; Almasaoud H; Alsubhi S; Alabdulazeem L; Alzahrani N; Alsaif S; Al Ghamdi K; Al-Asoom L
    Acta Biomed; 2023 Dec; 94(6):e2023259. PubMed ID: 38054673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory disorder in patients infected with SARS-CoV-2.
    Yen YF; Lai HH; Chan SY; Su VY; Chiu TF; Huang CY; Hung CC; Kuo TL; Lee YL; Chu D
    J Microbiol Immunol Infect; 2021 Oct; 54(5):992-996. PubMed ID: 32859529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia.
    Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS
    Saudi Med J; 2021 Jan; 42(1):38-43. PubMed ID: 33399169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan.
    Cheng MY; Hsih WH; Ho MW; Lai YC; Liao WC; Chen CY; Chen TC; Lee YL; Liu PY; Kao CC; Chou CH; Lin PC; Chi CY; Leong LY; Tai CJ; Lu MC
    J Microbiol Immunol Infect; 2021 Oct; 54(5):794-800. PubMed ID: 33610511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phantosmia May Predict Long-Term Measurable Olfactory Dysfunction After COVID-19.
    Leung JS; Cordano VP; Fuentes-López E; Lagos AE; García-Huidobro FG; Aliaga R; Díaz LA; García-Salum T; Salinas E; Toro A; Callejas CA; Riquelme A; Palmer JN; Medina RA; González G C
    Laryngoscope; 2022 Dec; 132(12):2445-2452. PubMed ID: 36149773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.
    Mercier J; Osman M; Bouiller K; Tipirdamaz C; Gendrin V; Chirouze C; Lepiller Q; Bouvier E; Royer PY; Pierron A; Toko L; Plantin J; Kadiane-Oussou NJ; Zayet S; Klopfenstein T
    J Med Virol; 2022 Oct; 94(10):4762-4775. PubMed ID: 35672249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.
    Hannum ME; Ramirez VA; Lipson SJ; Herriman RD; Toskala AK; Lin C; Joseph PV; Reed DR
    Chem Senses; 2020 Dec; 45(9):865-874. PubMed ID: 33245136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden olfactory loss as an early marker of COVID-19: a nationwide Italian survey.
    Spadera L; Viola P; Pisani D; Scarpa A; Malanga D; Sorrentino G; Madini E; Laria C; Aragona T; Leopardi G; Maggiore G; Ciriolo M; Boccuto L; Pizzolato R; Abenavoli L; Cassandro C; Ralli M; Cassandro E; Chiarella G
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):247-255. PubMed ID: 32749606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smell Status in Children Infected with SARS-CoV-2.
    Rusetsky Y; Meytel I; Mokoyan Z; Fisenko A; Babayan A; Malyavina U
    Laryngoscope; 2021 Aug; 131(8):E2475-E2480. PubMed ID: 33443298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression Symptoms and Olfactory-related Quality of Life.
    Liu DT; Prem B; Sharma G; Kaiser J; Besser G; Mueller CA
    Laryngoscope; 2022 Sep; 132(9):1829-1834. PubMed ID: 35353380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding olfactory dysfunction in the COVID-19 era: insights from a cross-sectional survey of the Saudi community.
    Aldrees T; Almatrafi S; Mokhatrish M; Aldriweesh T
    Front Public Health; 2023; 11():1258806. PubMed ID: 37869179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the relationship between olfactory-specific quality of life, objective olfactory loss, and patient factors in chronic rhinosinusitis.
    Mattos JL; Schlosser RJ; Storck KA; Soler ZM
    Int Forum Allergy Rhinol; 2017 Jul; 7(7):734-740. PubMed ID: 28519966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for anosmia and ageusia in patients presenting to the emergency department with suspected coronavirus disease 2019 in Saudi Arabia.
    Kentab OY; Ibrahim AAA; Soliman KR; Alanazi M; Alsunaid A; Ababtain A; Alresseeni AI; Algarni A; Aljohani K; Aljahany M
    J Int Med Res; 2022 May; 50(5):3000605221096280. PubMed ID: 35510652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Chemosensitive Neurological Disorders of Smell and Taste and Association with Blood Groups in SARS-CoV-2 Patients: Cross-Sectional Study.
    Al-Shouli ST; Meo SA; Alafaleq NO; Sumaily KM; Alshehri A; Almutairi A; Eidalsharif A; Alsulami F; Alhanaya S
    Viruses; 2023 May; 15(6):. PubMed ID: 37376577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of olfactory dysfunction persistence after COVID-19: a prospective study.
    Bianco MR; Ralli M; Minni A; Greco A; de Vincentiis M; Allegra E
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1042-1048. PubMed ID: 35179771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.